Register

COURSE DESCRIPTION: 
Please join us for a discussion on “Near-zero-knowledge Pattern Discovery for Universal Screening for Complex Disorders” with Ishanu Chattopadhyay, Ph.D. Dr. Chattopadhyay will evaluate the application of AI in Biomedicine and discuss why we need a “Bio”-AI. He will also discuss emerging tools for addressing late and missed diagnosis. Finally, he will explain how risk factors are often not predictive enough, and how to think about more personalized predictors of future risk of serious diseases.

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents,  Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Evaluate the application of artificial intelligence (AI) in biomedicine: why we need a Bio-AI.
• Discuss emerging tools for addressing late and missed diagnosis.
• Explain how risk factors are often not predictive enough, and how to think about more personalized predictors of future risk of serious diseases.

FACULTY AND DISCLOSURES:

Ishanu Chattopadhyay, Ph.D.
Assistant Professor, Department of Medicine
Section of Hospital Medicine
Center for Health Statistics 
Institute for Genomics and Systems Biology 
Committee on Genetics, Genomics & Systems Biology
Committee on Quantitative Methods in Social, Behavioral, and Health Sciences 
University of Chicago
Chicago, Illinois

Ishanu Chattopadhyay, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation will not include off-label or unapproved product usage.

John F. Rubin, M.D., FACP, director of this educational activity, has indicated that he is a shareholder in AstraZeneca and Bristol-Myers Squibb. All of the relevant financial relationships listed for this individual have been mitigated.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.